ArticleBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2025

ESR1 overexpression is a biomarker of relapse and worse prognosis in stage I endometrioid endometrial carcinoma.

C B P Chaves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.